408 related articles for article (PubMed ID: 33739897)
1. The challenges of generalizability in artificial intelligence for ADME/Tox endpoint and activity prediction.
Huang DZ; Baber JC; Bahmanyar SS
Expert Opin Drug Discov; 2021 Sep; 16(9):1045-1056. PubMed ID: 33739897
[TBL] [Abstract][Full Text] [Related]
2. Applying machine learning techniques for ADME-Tox prediction: a review.
Maltarollo VG; Gertrudes JC; Oliveira PR; Honorio KM
Expert Opin Drug Metab Toxicol; 2015 Feb; 11(2):259-71. PubMed ID: 25440524
[TBL] [Abstract][Full Text] [Related]
3. Artificial intelligence in drug discovery: recent advances and future perspectives.
Jiménez-Luna J; Grisoni F; Weskamp N; Schneider G
Expert Opin Drug Discov; 2021 Sep; 16(9):949-959. PubMed ID: 33779453
[No Abstract] [Full Text] [Related]
4. Critical assessment of AI in drug discovery.
Walters WP; Barzilay R
Expert Opin Drug Discov; 2021 Sep; 16(9):937-947. PubMed ID: 33870801
[No Abstract] [Full Text] [Related]
5. A Review on Deep Learning-driven Drug Discovery: Strategies, Tools and Applications.
Sumathi S; Suganya K; Swathi K; Sudha B; Poornima A; Varghese CA; Aswathy R
Curr Pharm Des; 2023 May; 29(13):1013-1025. PubMed ID: 37055908
[TBL] [Abstract][Full Text] [Related]
6. Predictive Multitask Deep Neural Network Models for ADME-Tox Properties: Learning from Large Data Sets.
Wenzel J; Matter H; Schmidt F
J Chem Inf Model; 2019 Mar; 59(3):1253-1268. PubMed ID: 30615828
[TBL] [Abstract][Full Text] [Related]
7. Artificial intelligence in drug design.
Zhong F; Xing J; Li X; Liu X; Fu Z; Xiong Z; Lu D; Wu X; Zhao J; Tan X; Li F; Luo X; Li Z; Chen K; Zheng M; Jiang H
Sci China Life Sci; 2018 Oct; 61(10):1191-1204. PubMed ID: 30054833
[TBL] [Abstract][Full Text] [Related]
8. Exploring the artificial intelligence and machine learning models in the context of drug design difficulties and future potential for the pharmaceutical sectors.
Shiammala PN; Duraimutharasan NKB; Vaseeharan B; Alothaim AS; Al-Malki ES; Snekaa B; Safi SZ; Singh SK; Velmurugan D; Selvaraj C
Methods; 2023 Nov; 219():82-94. PubMed ID: 37778659
[TBL] [Abstract][Full Text] [Related]
9. Artificial Intelligence and Machine Learning Technology Driven Modern Drug Discovery and Development.
Sarkar C; Das B; Rawat VS; Wahlang JB; Nongpiur A; Tiewsoh I; Lyngdoh NM; Das D; Bidarolli M; Sony HT
Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768346
[TBL] [Abstract][Full Text] [Related]
10. Deep learning tools to accelerate antibiotic discovery.
Cesaro A; Bagheri M; Torres M; Wan F; de la Fuente-Nunez C
Expert Opin Drug Discov; 2023; 18(11):1245-1257. PubMed ID: 37794737
[TBL] [Abstract][Full Text] [Related]
11. Concepts of Artificial Intelligence for Computer-Assisted Drug Discovery.
Yang X; Wang Y; Byrne R; Schneider G; Yang S
Chem Rev; 2019 Sep; 119(18):10520-10594. PubMed ID: 31294972
[TBL] [Abstract][Full Text] [Related]
12. Success stories of AI in drug discovery - where do things stand?
Mak KK; Balijepalli MK; Pichika MR
Expert Opin Drug Discov; 2022 Jan; 17(1):79-92. PubMed ID: 34553659
[TBL] [Abstract][Full Text] [Related]
13. New avenues in artificial-intelligence-assisted drug discovery.
Cerchia C; Lavecchia A
Drug Discov Today; 2023 Apr; 28(4):103516. PubMed ID: 36736583
[TBL] [Abstract][Full Text] [Related]
14. Integrating clinical pharmacology and artificial intelligence: potential benefits, challenges, and role of clinical pharmacologists.
Singh H; Nim DK; Randhawa AS; Ahluwalia S
Expert Rev Clin Pharmacol; 2024 Apr; 17(4):381-391. PubMed ID: 38340012
[TBL] [Abstract][Full Text] [Related]
15. Machine Learning and Artificial Intelligence: A Paradigm Shift in Big Data-Driven Drug Design and Discovery.
Pasrija P; Jha P; Upadhyaya P; Khan MS; Chopra M
Curr Top Med Chem; 2022; 22(20):1692-1727. PubMed ID: 35786336
[TBL] [Abstract][Full Text] [Related]
16. Opportunities and challenges using artificial intelligence in ADME/Tox.
Bhhatarai B; Walters WP; Hop CECA; Lanza G; Ekins S
Nat Mater; 2019 May; 18(5):418-422. PubMed ID: 31000801
[TBL] [Abstract][Full Text] [Related]
17. AI in drug development: a multidisciplinary perspective.
Gallego V; Naveiro R; Roca C; Ríos Insua D; Campillo NE
Mol Divers; 2021 Aug; 25(3):1461-1479. PubMed ID: 34251580
[TBL] [Abstract][Full Text] [Related]
18. Artificial intelligence in small molecule drug discovery from 2018 to 2023: Does it really work?
Lv Q; Zhou F; Liu X; Zhi L
Bioorg Chem; 2023 Dec; 141():106894. PubMed ID: 37776682
[TBL] [Abstract][Full Text] [Related]
19. The machine learning life cycle and the cloud: implications for drug discovery.
Spjuth O; Frid J; Hellander A
Expert Opin Drug Discov; 2021 Sep; 16(9):1071-1079. PubMed ID: 34057379
[No Abstract] [Full Text] [Related]
20. Guided structure-based ligand identification and design via artificial intelligence modeling.
Di Filippo JI; Cavasotto CN
Expert Opin Drug Discov; 2022 Jan; 17(1):71-78. PubMed ID: 34544293
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
